Star Health and Allied Insurance Company Ltd.

NSE: STARHEALTH | BSE: 543412

Mid-range Performer

Download real time

428.65 -7.70 (-1.76%)

33.75% Fall from 52W High

636.3K NSE+BSE Volume

NSE 19 Jun, 2025 2:26 PM (IST)

25,190.9

Market Cap

Low in industry

0.6

Beta 1Year

Very Low volatility

Star Health and Allied Insurance Company Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for STARHEALTH, BSE:543412 Star Health and Allied Insurance Company Ltd.

Search Inside the pdf :

Star Health and Allied Insurance Company Ltd.

14 May 2025

428.65

-1.76%

STAR HEALTH AND ALLIED INSURANCE COMPANY LIMITED

Hold: Star Health and Allied Ins...

Target

Geojit BNP Paribas

The company is currently facing challenges due to the new accounting standards and a surge in claim frequency and severity, which are affecting its profitability. However, recent price adjustments are expected to mitigate the impact of rising medical costs and hospitalisation trends, potentially leading to a gradual decline in the claims ratio over the next few quarters. A potential reduction in expense ratios and stable commission ratios are expected as the company grows. Additionally, the company is adopting a targeted approach by focusing on specific market segments...

Number of FII/FPI investors increased from 215 to 231 in Mar 2025 qtr.

Star Health and Allied Insurance Company Ltd.

13 Feb 2025

428.65

-1.76%

STAR HEALTH AND ALLIED INSURANCE COMPANY LIMITED

Hold: Star Health and Allied Ins...

Recommendation Target

Geojit BNP Paribas

Star Health and Alli.. has an average target of 600.80 from 5 brokers.

Star Health and Allied Insurance Company Ltd.

30 Jan 2025

428.65

-1.76%

Arduous journey toward gradual recovery in claims ratio

Buy: Star Health and Allied Ins...

Recommendation

Emkay

Star Health reported weak performance for Q3FY25, with GWP growth at 5.3% (at a 1.8% miss) impacted by implementation of the 1/n regulation and Combined Ratio at 103.3% vs our estimate of 100.5% driven by higher Claims and Expense Ratio (affected by 1/n premium accounting of long-term policies).

Star Health and Allied Insurance Company Ltd. is trading above its 150 day SMA of 426.9

Star Health and Allied Insurance Company Ltd.

11 Nov 2024

428.65

-1.76%

Star Health Allied Ins. Co.

Buy: Star Health and Allied Ins...

Target

ICICI Direct

Number of FII/FPI investors increased from 215 to 231 in Mar 2025 qtr.

Star Health and Allied Insurance Company Ltd.

04 Sep 2024

428.65

-1.76%

STAR HEALTH AND ALLIED INSURANCE COMPANY LIMITED

Buy: Star Health and Allied Ins...

Target

Geojit BNP Paribas

Number of FII/FPI investors increased from 215 to 231 in Mar 2025 qtr.

Star Health and Allied Insurance Company Ltd.

26 Aug 2024

428.65

-1.76%

Star Health Allied Ins. Co.

Buy: Star Health and Allied Ins...

Target

ICICI Direct

Star Health and Alli.. has an average target of 600.80 from 5 brokers.

Star Health and Allied Insurance Company Ltd.

04 Aug 2024

428.65

-1.76%

FY25 may accrue benefits of price hikes, new channels and better investment performance

Buy: Star Health and Allied Ins...

ICICI Securities Limited

Star Health and Allied Insurance’s (Star) Q1FY25 profit of INR 3.2bn was in line with our estimate driven by better than-expected investment performance, offsetting the impact of higher-than-expected claims ratio.

Star Health and Allied Insurance Company Ltd. has gained 20.92% in the last 3 Months

Star Health and Allied Insurance Company Ltd.

28 Jun 2024

428.65

-1.76%

Earnings outlook gets lifted with COR improvement outlook; compliments strong industry position

Buy: Star Health and Allied Ins...

Target

ICICI Securities Limited

We attended Star Health’s (Star) ‘Investor and Analyst Day’ on 27 Jun’24 in Chennai. Star is building well on its vantage in the retail segment via a well-concerted strategy encompassing distribution, product innovation, superior claims processing and enhanced underwriting.

Star Health and Allied Insurance Company Ltd. has gained 20.92% in the last 3 Months

Star Health and Allied Insurance Company Ltd.

28 Jun 2024

428.65

-1.76%

Focusing on profitable growth

Buy: Star Health and Allied Ins...

Motilal Oswal

Overall, the company aims to double its GWP and triple its PAT by FY28. We estimate STARHEAL to deliver FY26E combined ratio/RoE of 94.9%/17.0%. We reiterate our BUY rating with a TP of INR730.

Star Health and Allied Insurance Company Ltd. has gained 20.92% in the last 3 Months

VOTE: Is Star Health and Allied Insurance Company Ltd. worth buying?

142 Votes:

Buy 85.21%

Sell 9.86%

Hold 4.93%

RESEARCH REPORTS

Hold SEE REPORTS >

pdf

Hold SEE REPORTS >

pdf